Category: Press Release - Page 20 - Psychedelic Alpha

Read more about the article FILAMENT HEALTH AND PHARMALA BIOTECH ANNOUNCE RELEASE OF GMP MDMA CAPSULES

FILAMENT HEALTH AND PHARMALA BIOTECH ANNOUNCE RELEASE OF GMP MDMA CAPSULES

Post published:April 11, 2023
Post category:Press Release

Read more about the article Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

Numinus Launches new Clinic Licensing Platform, the Numinus Network, to Accelerate Expansion

Post published:April 11, 2023
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP FILES PROSPECTUS SUPPLEMENT AND ANNOUNCES CLOSING UNDER SHARE SUBSCRIPTION AGREEMENT

Post published:April 10, 2023
Post category:Press Release

Read more about the article COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference

COMPASS Pathways to participate in upcoming 22nd Annual Needham Virtual Healthcare Conference

Post published:April 10, 2023
Post category:Press Release

Read more about the article Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Bright Minds Biosciences to Present at the 20th International Meeting of the International Society for Serotonin Research

Post published:April 10, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Closes US$3.5 Million Public Offering

Clearmind Medicine Closes US$3.5 Million Public Offering

Post published:April 6, 2023
Post category:Press Release

Read more about the article Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Small Pharma Announces Positive Six-month Data from Phase IIa Trial of SPL026

Post published:April 4, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering

Clearmind Medicine Announces Pricing of US$3.5 Million Public Offering

Post published:April 4, 2023
Post category:Press Release

Read more about the article Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1 DMT Clinical Study

Algernon NeuroScience Announces Successful Dosing of 2nd Cohort in Phase 1 DMT Clinical Study

Post published:April 4, 2023
Post category:Press Release

Read more about the article First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health

First Avenue Ventures Life Science Fund I Invests in Diamond Therapeutics to Accelerate Innovation in Mental Health

Post published:April 4, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.